Cassidy's 340B Crackdown: Hospitals Face New Fiscal Headwinds Amid Funding Cuts

The 340B drug discount program, established in 1992, enables hospitals and clinics serving low-income and uninsured patients to purchase outpatient drugs at significantly reduced prices, funding vital services. However, this critical revenue stream now faces unprecedented scrutiny, with Senator Bill Cassidy leading a bipartisan charge for sweeping reforms. His proposed limits on the 340B program threaten to unleash a fresh wave of fiscal headwinds upon a hospital sector already grappling with inflation, persistent labor shortages, and declining reimbursement rates. These potential changes could severely impact patient care and jeopardize access to essential services for millions of vulnerable Americans.